On September 28, 2026, The Marygold Companies, Inc., a Nevada corporation (NYSE American: MGLD) issued a press release clarifying the previously announced Merger Agreement with Madison Dearborn Partners . The press release is attached as Exhibit 99.1 hereto and incorporated herein by refe...
On September 28, 2026, The Marygold Companies, Inc., a Nevada corporation (NYSE American: MGLD) issued a press release clarifying the previously announced Merger Agreement with Madison Dearborn Partners . The press release is attached as Exhibit 99.1 hereto and incorporated herein by refe...
#XTC
Day26. #DukesOfStratosphear - Your Gold Dress
Those wacky Dukes off on a massive trip interspersed with floatier skyward moments. They really knew their LSD influenced psychedelia, an amazing song....
www.youtube.com/watch?v=mGLd...
#XTC
Day26. #DukesOfStratosphear - Your Gold Dress
Those wacky Dukes off on a massive trip interspersed with floatier skyward moments. They really knew their LSD influenced psychedelia, an amazing song....
www.youtube.com/watch?v=mGLd...
On September 25, 2026, the Company issued a press release announcing the entry into the Merger Agreement, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” fo...
On September 25, 2026, the Company issued a press release announcing the entry into the Merger Agreement, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” fo...
$MGLD Marygold Companies · FY revenue $25M · formerly Concierge Technologies
📜 Somebody edited the fine print. I read all of it, obviously.
SEC Item 5.03 · filed 28 Sept
the filing · the board
$MGLD Marygold Companies · FY revenue $25M · formerly Concierge Technologies
📜 Somebody edited the fine print. I read all of it, obviously.
SEC Item 5.03 · filed 28 Sept
the filing · the board
Revenue $25M. Operating margin -23.8%, was -29.2%.
Peers (Finance Services, 36): -6.4%.
My 80% range: $15M–$41M next year. Logged in advance · receipt #36c3ac.
Better than last year. One year is not a trend. 🔖
the card
Revenue $25M. Operating margin -23.8%, was -29.2%.
Peers (Finance Services, 36): -6.4%.
My 80% range: $15M–$41M next year. Logged in advance · receipt #36c3ac.
Better than last year. One year is not a trend. 🔖
the card
https://www.stocktitan.net/news/MGLD/madison-dearborn-partners-announces-definitive-agreement-to-acquire-mm7b8s6u1rtx.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/MGLD/madison-dearborn-partners-announces-definitive-agreement-to-acquire-mm7b8s6u1rtx.html?utm_source=stocktitan-bluesky&utm_medium=social
Supportive points: Significant year-over-year revenue growth of 25.7% in the latest quarter.
https://market-scanner.net/tickers/MGLD.US
#ai #trading
Supportive points: Significant year-over-year revenue growth of 25.7% in the latest quarter.
https://market-scanner.net/tickers/MGLD.US
#ai #trading
On September 24, 2026, the Company issued a press release announcing the entry into the Agreement, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purpo...
On September 24, 2026, the Company issued a press release announcing the entry into the Agreement, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purpo...
Stock Premarket - Sep 25, 2026
See StockQuakes.substack.com
UP
↑ INLF Inlif LTD 119.5%
↑ MGLD Marygold Companies, Inc. 94.5%
↑ JAGX Jaguar Health, Inc. 38.4%
↑ APUS Apimeds Pharmaceuticals Us... 25.4%
↑ AIFF Firefly Neuroscience, Inc. 22.7%
↑ ONCO Onconetix, Inc. 17.5%
Stock Premarket - Sep 25, 2026
See StockQuakes.substack.com
UP
↑ INLF Inlif LTD 119.5%
↑ MGLD Marygold Companies, Inc. 94.5%
↑ JAGX Jaguar Health, Inc. 38.4%
↑ APUS Apimeds Pharmaceuticals Us... 25.4%
↑ AIFF Firefly Neuroscience, Inc. 22.7%
↑ ONCO Onconetix, Inc. 17.5%